rucaparib 250 MG Oral Tablet
- RxCUI
- 1921587
- RxNorm name
- rucaparib 250 MG Oral Tablet
- Display name
- rucaparib 250 MG Oral Tablet
- Full name
- rucaparib 250 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:45
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rubraca | RUCAPARIB | pharmaand GmbH | 0295d202-1cfe-7659-e063-6294a90a476e | 2025-12-31 | Warnings, Adverse reactions | 1921587 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 0295d202-1cfe-7659-e063-6294a90a476e | rucaparib 250 MG Oral Tablet | PSN | 19 | These highlights do not include all the information needed to use RUBRACA safely and effectively. See full prescribing information for RUBRACA. RUBRACA ® (rucaparib) tablets, for oral use Initial U.S. Approval: 2016 | 20251231 |
| 0295d202-1cfe-7659-e063-6294a90a476e | rucaparib 250 MG Oral Tablet | SCD | 19 | These highlights do not include all the information needed to use RUBRACA safely and effectively. See full prescribing information for RUBRACA. RUBRACA ® (rucaparib) tablets, for oral use Initial U.S. Approval: 2016 | 20251231 |
| 0295d202-1cfe-7659-e063-6294a90a476e | rucaparib (as rucaparib camisylate) 250 MG Oral Tablet | SY | 19 | These highlights do not include all the information needed to use RUBRACA safely and effectively. See full prescribing information for RUBRACA. RUBRACA ® (rucaparib) tablets, for oral use Initial U.S. Approval: 2016 | 20251231 |